MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
series b convertible...
$5,265K
Net cash provided by
financing activities
$4,952K
Canceled cashflow
$313K
Net increase in cash
$2,824K
Canceled cashflow
$2,128K
Principal payments under
notes payable
$313K
Accounts receivable
-$2,423K
Loss (gain) on
revaluation of warrant...
-$727K
Accounts payable
$679K
Depreciation and
amortization
$454K
Changes in provision for
credit losses on...
$323K
Unrealized loss (gain) on
foreign currency...
-$239K
Inventories
-$168K
Finance cost associated
with warrant...
$145K
Stock-based compensation
expense
$114K
Loss on impairment of
right-of-use asset
$89K
Net cash used in
operating activities
-$2,123K
Effect of exchange rate
changes on cash
-$5K
Canceled cashflow
$5,361K
Net loss
-$6,885K
Deferred revenues
-$296K
Accrued, lease and other
liabilities, current and...
-$188K
Prepaid expenses and
other assets, current...
$115K
Back
Back
Cash Flow
EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC. (EKSO)
source: myfinsight.com